
Topic
Formulary Strategy
Tiering, exclusions, preferred products, step therapy, and how access teams prepare the evidence packet.

Pricing & Access· May 16, 2026 · 10 min read
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 15, 2026 · 8 min read
Mounjaro coverage guide: formulary, prior authorization, and what access teams should know
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 15, 2026 · 9 min read
Ozempic vs Mounjaro: label, access, and payer coverage compared
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 15, 2026 · 9 min read
Zepbound coverage guide: formulary, prior authorization, and what access teams should know
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 14, 2026 · 8 min read
Ozempic coverage guide: formulary, prior authorization, and what access teams should know
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 14, 2026 · 8 min read
Ozempic vs Wegovy: label, access, and payer coverage compared
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 14, 2026 · 8 min read
Wegovy coverage guide: formulary, prior authorization, and what access teams should know
By Ran Chen#GLP-1#Prior Authorization#Payer Policy

Pricing & Access· May 12, 2026 · 4 min read
The payer coverage matrix specialty drug launches actually need

Pricing & Access· May 11, 2026 · 4 min read